• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

遵守关于基本药物福利的州和联邦法规:实施《平价医疗法案》。

Complying with state and federal regulations on essential drug benefits: implementing the Affordable Care Act.

作者信息

Cohen Joshua P, Felix Abigail, Vasiadi Magdalini

机构信息

Tufts Center for the Center of Drug Development, School of Medicine, 75 Kneeland St, Boston, MA 02111. E-mail:

出版信息

Am J Manag Care. 2014 Feb;20(2):153-8.

PMID:24738533
Abstract

OBJECTIVES

To examine health plan compliance with essential drug benefit regulations in California and Massachusetts and at the federal level.

STUDY DESIGN

Health plan formulary review and analysis.

METHODS

We analyzed formularies from the 3 largest small group plans in California and Massachusetts, including each state's benchmark plan. With respect to both federal and state regulations, for each health plan, we examined whether the drug was covered, the designated patient cost sharing tier of the drug, and which conditions of reimbursement were applied to the drug.

RESULTS

Most drugs included in state and federal mandates are covered by both benchmark and non-benchmark plans. However, health plans are not fully compliant with state and federal regulations. Significant differences among plans relate more to cost sharing and conditions of reimbursement, such as prior authorization, step edits, and quantity limits, than to drug coverage. CONCLUSIONS/POLICY IMPLICATIONS: Because health plans in California and Massachusetts are not fully compliant with state and federal mandates, they will have to adjust their formularies to meet minimum requirements. State policy makers need to balance competing aims of comprehensiveness of coverage and drug affordability. They must consider: (1) choice of benchmark plan -choice of a more generous benchmark plan implies less leverage for negotiating lower prices; and (2) breadth of state mandates which, if they exceed federal mandates, must be paid for by the states.

摘要

目标

研究加利福尼亚州、马萨诸塞州以及联邦层面的医保计划对基本药物福利法规的遵守情况。

研究设计

医保计划处方集审查与分析。

方法

我们分析了加利福尼亚州和马萨诸塞州最大的3个小团体医保计划的处方集,包括每个州的基准计划。对于联邦和州法规,针对每个医保计划,我们审查了药物是否被涵盖、药物指定的患者费用分摊等级,以及哪些报销条件适用于该药物。

结果

州和联邦规定中包含的大多数药物都被基准计划和非基准计划所涵盖。然而,医保计划并未完全遵守州和联邦法规。计划之间的显著差异更多地与费用分摊和报销条件有关,如预先授权、逐步调整和数量限制,而非药物覆盖范围。结论/政策启示:由于加利福尼亚州和马萨诸塞州的医保计划未完全遵守州和联邦规定,它们将不得不调整其处方集以满足最低要求。州政策制定者需要在覆盖范围的全面性和药物可负担性这两个相互竞争的目标之间取得平衡。他们必须考虑:(1)基准计划的选择——选择更慷慨的基准计划意味着在谈判降低价格方面的影响力较小;(2)州规定的广度,如果州规定超过联邦规定,则必须由各州承担费用。

相似文献

1
Complying with state and federal regulations on essential drug benefits: implementing the Affordable Care Act.遵守关于基本药物福利的州和联邦法规:实施《平价医疗法案》。
Am J Manag Care. 2014 Feb;20(2):153-8.
2
Implementing the Affordable Care Act: choosing an essential health benefits benchmark plan.实施《平价医疗法案》:选择一项基本健康福利基准计划。
Issue Brief (Commonw Fund). 2013 Mar;15:1-14.
3
How are state insurance marketplaces shaping health plan design?州保险市场如何塑造健康保险计划的设计?
Issue Brief (Commonw Fund). 2013 Dec;33:1-12.
4
The ACA's pediatric essential health benefit has resulted in a state-by-state patchwork of coverage with exclusions.《平价医疗法案》的儿科基本健康福利导致了各州覆盖范围参差不齐且存在排除条款的情况。
Health Aff (Millwood). 2014 Dec;33(12):2136-43. doi: 10.1377/hlthaff.2014.0743.
5
Medicare program; Medicare prescription drug benefit. Final rule.医疗保险计划;医疗保险处方药福利。最终规则。
Fed Regist. 2005 Jan 28;70(18):4193-585.
6
Pharmaceuticals: Medicare Modernization Act--2005. End of Year Issue Brief.药品:《医疗保险现代化法案》——2005年。年终问题简报。
Issue Brief Health Policy Track Serv. 2005 Dec 31:1-21.
7
Basic health program: state administration of basic health programs; eligibility and enrollment in standard health plans; essential health benefits in standard health plans; performance standards for basic health programs; premium and cost sharing for basic health programs; federal funding process; trust fund and financial integrity. Final rule.基本健康计划:基本健康计划的国家管理;标准健康计划的资格与参保;标准健康计划中的基本健康福利;基本健康计划的绩效标准;基本健康计划的保费与费用分担;联邦资金流程;信托基金与财务诚信。最终规则。
Fed Regist. 2014 Mar 12;79(48):14111-51.
8
Group health plans and health insurance issuers relating to coverage of preventive services under the Patient Protection and Affordable Care Act. Final rules.与《患者保护与平价医疗法案》下预防性服务覆盖范围相关的团体健康计划和健康保险发行人。最终规则。
Fed Regist. 2012 Feb 15;77(31):8725-30.
9
Affording shared responsibility for universal coverage: insights from California.承担全民医保的共同责任:来自加利福尼亚州的见解
Health Aff (Millwood). 2009 May-Jun;28(3):w417-30. doi: 10.1377/hlthaff.28.3.w417. Epub 2009 Mar 24.
10
Comparing patient access to pharmaceuticals in the UK and US.比较英国和美国患者获取药品的情况。
Appl Health Econ Health Policy. 2006;5(3):177-87. doi: 10.2165/00148365-200605030-00004.